NYSE:TEVAPharmaceuticals
Is Teva (TEVA) Still Reasonably Priced After A 195% Three Year Share Price Gain
If you are wondering whether Teva Pharmaceutical Industries is still reasonably priced after its recent run, this article will walk through what the current share price might be implying about value.
Teva's stock last closed at US$32.47, with returns of 1.1% over 7 days, 9.0% over 30 days, 4.9% year to date, 54.8% over 1 year and 194.6% over 3 years. This naturally raises questions about how much of the story is already reflected in the price.
Recent coverage has focused on Teva as investors...